Anavex Life Sciences Statistics

Total Valuation

AVXL has a market cap or net worth of $393.13 million. The enterprise value is $290.55 million.

Market Cap	393.13M
Enterprise Value	290.55M

Important Dates

The last earnings date was Tuesday, November 25, 2025, before market open.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

AVXL has 89.35 million shares outstanding. The number of shares has increased by 2.18% in one year.

Current Share Class	89.35M
Shares Outstanding	89.35M
Shares Change (YoY)	+2.18%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	3.23%
Owned by Institutions (%)	36.64%
Float	86.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.02
P/TBV Ratio	4.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.60

Current Ratio	11.60
Quick Ratio	11.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.11% and return on invested capital (ROIC) is -29.49%.

Return on Equity (ROE)	-43.11%
Return on Assets (ROA)	-26.51%
Return on Invested Capital (ROIC)	-29.49%
Return on Capital Employed (ROCE)	-53.51%
Revenue Per Employee	n/a
Profits Per Employee	-$1.36M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.43% in the last 52 weeks. The beta is 1.15, so AVXL's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-51.43%
50-Day Moving Average	7.04
200-Day Moving Average	8.72
Relative Strength Index (RSI)	39.95
Average Volume (20 Days)	4,555,596

Short Selling Information

The latest short interest is 28.74 million, so 32.17% of the outstanding shares have been sold short.

Short Interest	28.74M
Short Previous Month	26.66M
Short % of Shares Out	32.17%
Short % of Float	33.24%
Short Ratio (days to cover)	11.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.76M
Pretax Income	-46.38M
Net Income	-46.38M
EBITDA	n/a
EBIT	-50.76M
Earnings Per Share (EPS)	-$0.54

Full Income Statement

Balance Sheet

The company has $102.58 million in cash and n/a in debt, giving a net cash position of $102.58 million or $1.15 per share.

Cash & Cash Equivalents	102.58M
Total Debt	n/a
Net Cash	102.58M
Net Cash Per Share	$1.15
Equity (Book Value)	94.87M
Book Value Per Share	1.09
Working Capital	94.87M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-39.04M
Capital Expenditures	n/a
Free Cash Flow	-39.04M
FCF Per Share	-$0.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.18%
Shareholder Yield	-2.18%
Earnings Yield	-11.80%
FCF Yield	-9.93%

Analyst Forecast

The average price target for AVXL is $22.00, which is 400.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	400.00%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 7, 2015. It was a reverse split with a ratio of 1:4.

Last Split Date	Oct 7, 2015
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2